Access cutting-edge lung transplant treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access lung transplant specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung transplant treatment provided free
This is a trial in which 350 primary lung transplant recipients will be randomized (1:1) to receive either Tocilizumab (six doses over 20 weeks) plus standard triple maintenance immunosuppression or placebo (sterile normal saline) plus standard triple maintenance immunosuppression (Tacrolimus, Mycophenolate Mofetil, corticosteroids). The primary objective is to test the hypothesis that treatment with triple maintenance immunosuppression plus Tocilizumab (TCZ) is superior to triple maintenance i
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Check if you qualify for this lung transplant clinical trial in Atlanta, GA
If you're searching for lung transplant treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.